Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05143138 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries

Study acronym: EMBRACE
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: W.L.Gore & Associates to W.L.Gore & Associates Show 4 more changesShow less
    • Study completion pushed from Dec 2026 to Mar 2027
    • Eligibility criteria expanded, about 11 words
    • Site details revised at 1 of 14 sites
    • Publications: details revised at 2 of 2 entries
  2. Results first posted: Aug 22, 2025
    • Primary endpoint revised
    • Study completion date: Jul 2026 to Dec 2026
    • Secondary endpoints shortened, about 47 words
    v9
  3. Re-verified, no change to tracked fieldsv8
  4. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 260 to confirmed 259
    • Site details revised at 14 of 14 sites
    v7
  5. Primary completion date: Oct 30, 2023 to Apr 30, 2024v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: Jun 30, 2023 to Oct 30, 2023v5
  2. Site details revised at 1 of 14 sitesv4
  3. Primary completion date: Dec 31, 2022 to Jun 30, 2023
    • Study sites: 12 to 14
    • Eligibility criteria expanded, about 8 words
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 9 to 12
    • Primary completion date: Jul 2022 to Dec 31, 2022
    • Start date changed from estimate of Apr 2022 to Mar 23, 2022
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Multicenter, single-arm retrospective and prospective registry is being conducted to confirm the clinical performance and safety of GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis when used as a Bridging Stent with Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries.
Trial Details
NCT Number NCT05143138
Lead Sponsor W.L.Gore & Associates
Conditions
(from sponsor)		 Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm
Related terms Aortic Aneurysm, Abdominal, Aortic Aneurysm, Thoracic
Enrollment 259 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov